Combined treatment with peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) and AAV-U7 rescues the severe DMD phenotype in mice
Duchenne muscular dystrophy (DMD) is a devastating neuromuscular disease caused by an absence of the dystrophin protein, which is essential for muscle fiber integrity. Among the developed therapeutic strategies for DMD, exon skipping approach corrects the frame shift and partially restores dystrophi...
Үндсэн зохиолчид: | Forand, A, Muchir, A, Mougenot, N, Sevoz-Couche, C, Peccate, C, Le Maitre, M, Izabelle, C, Wood, MJA, Lorain, S, Piétri-Rouxel, F |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2020
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers
-н: Li, Chengxi, зэрэг
Хэвлэсэн: (2021) -
MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
-н: Ning Ran, зэрэг
Хэвлэсэн: (2020-12-01) -
Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy
-н: Yoko Endo-Takahashi, зэрэг
Хэвлэсэн: (2025-02-01) -
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
-н: Cirak, S, зэрэг
Хэвлэсэн: (2011) -
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
-н: Cirak, S, зэрэг
Хэвлэсэн: (2011)